Targeting mitochondrial permeability in cancer drug development

Molecular Nutrition and Food Research

Volumn 53, Issue 1, 2009, Pages 76-86

  Berridge, Michael V ^a   Herst, Patries M ^a   Lawen, Alfons ^b  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Anticancer compound; Apoptosis; Cell death; Mitochondria; Permeability

Indexed keywords

2 METHOXY 5 (2,3,4 TRIMETHOXYPHENYL)TROPONE; 2-METHOXY-5-(2',3',4'-TRIMETHOXYPHENYL)TROPONE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; TROPOLONE;

APOPTOSIS; DRUG EFFECT; ENERGY METABOLISM; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NEOPLASM; PATHOLOGY; PERMEABILITY; PHYSIOLOGY; REVIEW; SYNTHESIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; NEOPLASMS; PERMEABILITY; TROPOLONE;

EID: 58149352994     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700493     Document Type: Review

References (142)

1. Skulachev, V. P., Bioenergetic aspects of apoptosis, necrosis and mitoptosis, Apoptosis 2006, 11, 473-485.
2. Orrenius, S., Mitochondrial regulation of apoptotic cell death, Toxicol, Lett. 2004, 149, 19-23.
3. Fulda, S., Debatin, K. M., Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy, Oncogene 2006, 25, 4798-4811.
4. Armstrong, J. S., Mitochondria: A target for cancer therapy. Br. J. Pharmacol 2006, 147, 239-248.
5. Danial, N. N., Korsmeyer, S. J., Cell death: Critical control points, Cell 2004, 116, 205-219.
6. Green, D. R., Kroemer, G., The pathophysiology of mitochondrial cell death, Science 2004, 305, 626-629.
7. Green, D. R., Reed, J. C., Mitochondria and apoptosis, Science 1998, 281, 1309-1312.
8. Kinnally, K. W., Antonsson, B., A tale of two mitochondrial channels, MAC and PTP, in apoptosis, Apoptosis 2007, 12, 857-668.
9. Lawen, A., Apoptosis-an introduction. Bioessays 2003, 25, 888-896.
10. Riedl, S. J., Salvesen, G. S., The apoptosome: Signalling platform of cell death, Nat. Rev. Mol Cell Biol. 2007, 8, 405-413.
11. Duchen, M. R., Mitochondria in health and disease: Perspectives on a new mitochondrial biology, Mol. Aspects Med. 2004, 25, 365-451.
12. Petit, P. X., Goubern, M., Diolez, P., Susin, S. A. et al., Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: The impact of irreversible permeability transition, FEBS Lett. 1998, 426, 111-116.
13. Yang, J. C., Cortopassi, G. A., Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c, Free Radic. Biol. Med. 1998, 24, 624-631.
14. Brown, M., Wilson, G., Apoptosis genes and resistance to cancer therapy. What do the experimental and clinical data tell us? Cancer Biol Ther. 2003, 2, 477-490.
15. Brenner, C., Grimm, S., The permeability transition pore complex in cancer cell death, Oncogene 2006, 25, 4744-4756.
16. Gogvadze, V., Orrenius, S., Zhivotovsky, B., Multiple pathways of cytochrome c release from mitochondria in apoptosis, Biochim. Biophys. Acta 2006, 1757, 639-647.
17. Yang, J., Liu, X., Bhalla, K., Kim, C. N. et al., Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked, Science 1997, 275, 1129-1132.
18. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., Wang, X., Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c, Cell 1996, 86, 147-157.
19. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I. et al. Molecular characterization of mitochondrial apoptosis-inducing factor, Nature 1999, 397, 441-446.
20. Du, C., Fang, M., Li, Y., Li, L., Wang, X., Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition, Cell 2000, 102, 33-42.
21. Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K. et al., A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death, Mol Cell. 2001, 8, 613-621.
22. m) in apoptosis; an update, Apoptosis 2003, 5, 115-128.
23. Zamzami, N., Marchetti, P., Castedo, M., Hirsch, T. et al., Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis, FEBS Lett. 1996, 384, 53-57.
24. Grubb, D. R., Ly, J. D., Vaillant, F., Johnson, K. L., Lawen, A., Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis, Oncogene 2001, 20, 4085-4094.
25. Garrido, C., Galluzzi, L., Brunet, M., Puig, P. E. et al., Mechanisms of cytochrome c release from mitochondria, Cell Death Differ. 2006, 13, 1423-1433.
26. Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T. et al., Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death, Science 2001, 292, 727-730.
27. Martinez-Caballero, S., Dejean, L. M., Kinnally, K. W., Some amphiphilic cations block the mitochondrial apoptosis-induced channel, MAC, FEBS Lett. 2004, 568, 35-38.
28. De Marchi, U., Campello, S., Szabo, I., Tombola, F. et al., Bax does not directly participate in the Ca(2+)-induced permeability transition of isolated mitochondria, J. Biol. Chem. 2004, 279, 37415-37422.
29. Narita, M., Shimizu, S., Ito, T., Chittenden, T. et al., Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria, Proc. Natl. Acad. Sci. USA 1998, 95, 14681-14686.
30. Shimizu, S., Tsujimoto, Y., Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity, Proc. Natl. Acad. Sci. USA 2000, 97, 577-582.
31. Berrieman, H. K., Smith, L., O'Kane, S. L., Campbell, A. et al., The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes, Cancer 2005, 103, 1415-1419.
32. Kubli, D. A., Ycaza, J. E., Gustafsson, A. B., Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak, Biochem. J. 2007, 405, 407-415.
33. Erlanson-Albertsson, C., The role of uncoupling proteins in the regulation of metabolism, Acta Physiol Scand. 2003, 775, 405-412.
34. Baines, C. P., Kaiser, R. A., Sheiko, T., Craigen, W. J., Molkentin, J. D., Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death, Nat. Cell Biol 2007, 9, 550-555.
35. Kokoszka, J. E., Waymire, K. G., Levy, S. E., Sligh, J. E. et al., The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore, Nature 2004, 427, 461-465.
36. Krauskopf, A., Eriksson, O., Craigen, W. J., Forte, M. A., Bernardi, P., Properties of the permeability transition in VDAC1(-/-) mitochondria, Biochim. Biophys. Acta 2006, 7757, 590-595.
37. Schinzel, A. C., Takeuchi, O., Huang, Z., Fisher, J. K. et al., Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia, Proc. Natl Acad. Sci. USA 2005, 102, 12005-12010.
38. Dias, N., Bailly, C., Drugs targeting mitochondrial functions to control tumor cell growth, Biochem. Pharmacol. 2005, 70, 1-12.
39. Don, A. S., Hogg, P. J., Mitochondria as cancer drug targets, Trends Mol Med. 2004, 10, 372-378.
40. Halestrap, A., Biochemistry: A pore way to die. Nature 2005, 454, 578-579.
41. Zoratti, M., Szabo, I., The mitochondrial permeability transition, Biochim. Biophys. Acta 1995, 1241, 139-176.
42. Galluzzi, L., Larochette, N., Zamzami, N., Kroemer, G., Mitochondria as therapeutic targets for cancer chemotherapy, Oncogene 2006, 25, 4812-4830.
43. Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J. et al., RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels, Nature 2007, 447, 864-868.
44. Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S. et al., Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death, Nature 2005, 434, 658-662.
45. Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O. et al., Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death, Nature 2005, 434, 652-658.
46. Pereira, C., Camougrand, N., Manon, S., Sousa, M. J., Corte-Real, M., ADP/ATP carrier is required for mitochondrial outer membrane permeabilization and cytochrome c release in yeast apoptosis, Mol. Microbiol. 2007, 66, 571-582.
47. Lawen, A., Another piece of the puzzle of apoptotic cytochrome c release. Mol. Microbiol. 2007, 66, 553-556.
48. Carroll, A. K., Clevenger, W. R., Szabo, T., Ackermann, L. E. et al., Ectopic expression of the human adenine nucleotide translocase, isoform 3 (ANT-3). Characterization of ligand binding properties, Mitochondrion 2005, 5, 1-13.
49. Yang, Z., Cheng, W., Hong, L., Chen, W. et al., Adenine nucleotide (ADP/ATP) translocase 3 participates in the tumor necrosis factor induced apoptosis of MCF-7 cells, Mol. Biol. Cell. 2007, 18, 4681-4689.
50. Dolce, V., Scarcia, P., Iacopetta, D., Palmieri, F., A fourth ADP/ATP carrier isoform in man: Identification, bacterial expression, functional characterization and tissue distribution, FEBS Lett. 2005, 579, 633-637.
51. Halestrap, A. P., Mitochondrial permeability: Dual role for the ADP/ATP translocator? Nature 2004, 430, 984.
52. Kroemer, G., Galluzzi, L., Brenner, C., Mitochondrial membrane permeabilization in cell death, Physiol. Rev. 2007, 87, 99-163.
53. Hanahan, D., Weinberg, R. A., The hallmarks of cancer, Cell 2000, 100, 57-70.
54. Isoldi, M. C., Visconti, M. A., Castrucci, A. M., Anti-cancer drugs: Molecular mechanisms of action. Mini Rev. Med. Chem. 2005, 5, 685-695.
55. Roos, W. P., Kaina, B., DNA damage-induced cell death by apoptosis, Trends Mol. Med. 2006, 12, 440-450.
56. Albayrak, T., Scherhammer, V., Schoenfeld, N., Braziulis, E. et al., The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction, Mol. Biol. Cell. 2003, 14, 3082-3096.
57. Zheng, Y., Shi, Y., Tian, C., Jiang, C. et al., Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide, Oncogene 2004, 23, 1239-1247.
58. Ganote, C. E., Armstrong, S. C., Effects of CCCP-induced mitochondrial uncoupling and cyclosporin A on cell volume, cell injury and preconditioning protection of isolated rabbit cardiomyocytes, J. Mol. Cell. Cardiol. 2003, 35, 749-759.
59. Douer, D., Tallman, M. S., Arsenic trioxide: New clinical experience with an old medication in hematologic malignancies, J. Clin. Oncol. 2005, 23, 2396-2410.
60. Verstovsek, S., Giles, F., Quintas-Cardama, A., Perez, N. et al., Arsenic derivatives in hematologic malignancies: A role beyond acute promyelocytic leukemia? Hematol. Oncol. 2006, 24, 181-188.
61. 2+ trigger site, Arch. Biochem. Biophys. 1979, 195, 460-467.
62. 2+, Biochemistry 1996, 35, 8483-8488.
63. Crompton, M., Mitochondrial intermembrane junctional complexes and their role in cell death, J. Physiol. 2000, 529, 11-21.
64. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress, Biochem. J. 1988, 255, 357-360.
65. Crompton, M., Virji, S., Ward, J. M., Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore, Eur. J. Biochem. 1998, 258, 729-735.
66. Woodfield, K., Ruck, A., Brdiczka, D., Halestrap, A. P., Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem. J. 1998, 336, 287-290.
67. Kowaltowski, A. J., Castilho, R. F., Vercesi, A. E., Mitochondrial permeability transition and oxidative stress. FEBS Lett. 2001, 495, 12-15.
68. Fiore, C., Trezeguet, V., Le Saux, A., Roux, P. et al., The mitochondrial ADP/ATP carrier: Structural, physiological and pathological aspects. Biochimie 1998, 80, 137-150.
69. Obatomi, D. K., Bach, P. H., Inhibition of mitochondrial respiration and oxygen uptake in isolated rat renal tubular fragments by atractyloside, Toxicol. Lett. 1996, 89, 155-161.
70. 2+ and oxidant stress, Eur, J. Biochem. 1996, 238, 166-172.
71. Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H. et al., Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 1998, 273, 33942-33948.
72. Marchetti, P., Zamzami, N., Joseph, B., Schraen-Maschke, S. et al., The novel retinoid 6-[3-(1-adamantyl)-4-hydroxy-phenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus, Cancer Res. 1999, 59, 6257-6266.
73. Ravagnan, L., Marzo, I., Costantini, P., Susin, S. A. et al., Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene 1999, 75, 2537-2546.
74. Stryker, J. A., Gerweck, L. E., Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization. Radial. Res. 1988, 113, 356-361.
75. Belzacq, A. S., El Hamel, C., Vieira, H. L., Cohen, I. et al., Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437, Oncogene 2001, 20, 7579-7587.
76. Pfeiffer, D. R., Gudz, T. I., Novgorodov, S. A., Erdahl, W. L., The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition, J. Biol. Chem. 1995, 270, 4923-4932.
77. Yu, K., Kang, S., Park, N., Shin, J., Kim, Y., Relationship between the tertiary structures of mastoparan B and its analogs and their lytic activities studied by NMR spectroscopy, J. Pept. Res. 2000, 55, 51-62.
78. Yokokawa, N., Komatsu, M., Takeda, T., Aizawa, T., Yamada, T., Mastoparan, a wasp venom, stimulates insulin release by pancreatic islets through pertussis toxin sensitive GTP-binding protein, Biochem. Biophys. Res. Commun. 1989, 158, 712-716.
79. Isakovic, A., Harhaji, L., Stevanovic, D., Markovic, Z. et al., Dual antiglioma action of metformin: Cell cycle arrest and mitochondria- dependent apoptosis, Cell. Mol. Life Sci. 2007, 64, 1290-1302.
80. Li, J., Wang, J., Zeng, Y., Peripheral benzodiazepine receptor ligand, PK11195 induces mitochondria cytochrome c release and dissipation of mitochondria potential via induction of mitochondria permeability transition, Eur. J. Pharmacol. 2007, 560, 117-122.
81. Li, L., Han, W., Gu, Y., Qiu, S. et al., Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore, Cancer Res. 2007, 67, 4894-4903.
82. Kluza, J., Gallego, M. A., Loyens, A., Beauvillain, J. C. et al., Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D, Cancer Res. 2006, 66, 3177-3187.
83. Yeh, T. C., Chiang, P. C., Li, T. K., Hsu, J. L. et al., Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult, Biochem. Pharmacol. 2007, 73, 782-792.
84. Kajimoto, S., Takanashi, N., Kajimoto, T., Xu, M. et al., Sophoranone, extracted from a traditional Chinese medicine Shan Dou Gen, induces apoptosis in human leukemia U937 cells via formation of reactive oxygen species and opening of mitochondrial permeability transition pores. Int. J. Cancer. 2002, 99, 879-890.
85. Via, L. D., Marini, A. M. Salerno, S., Toninello, A., Mitochondrial permeability transition induced by novel Pyridothiopyranopyrimidine derivatives: potential new antimitochondrial antitumour agents, Biochem. Pharmacol. 2006, 72, 1657-1667.
86. Perchellet, E. M., Wang, Y., Lou, K., Zhao, H. et al., Novel substituted 1, 4-anthracenediones with antitumor activity directly induce permeability transition in isolated mitochondria, Int. J. Oncol. 2007, 31, 1231-1241.
87. Jacotot, E., Ravagnan, L., Loeffler, M., Ferri, K. F. et al., The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore, J. Exp. Med. 2000, 191, 33-46.
88. Brookes, P. S., Morse, K., Ray, D., Tompkins, A. et al., The triterpenoid 2-cyano-3, 12-dioxooleana-1, 9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore, Cancer Res. 2007, 67, 1793-1802.
89. Oliveira, P. J., Wallace, K. B., Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats - relevance for mitochondrial dysfunction, Toxicology 2006, 220, 160-168.
90. Kerkela, R., Grazette, L., Yacobi, R., Iliescu, C. et al., Cardiotoxicity of the cancer therapeutic agent imatinib mesylate, Nat. Med. 2006, 12, 908-916.
91. Henderson, P. J., Lardy, H. A., Bongkrekic acid. An inhibitor of the adenine nucleotide translocase of mitochondria, J. Biol. Chem. 1970, 245, 1319-1326.
92. Klingenberg, M., Grebe, K., Heldt, H. W., On the inhibition of the adenine nucleotide translocation by bongkrekic acid, Biochem. Biophys. Res. Commun. 1970, 39, 344-351.
93. Machida, K., Hayashi, Y., Osada, H., A novel adenine nucleotide translocase inhibitor, MT-21, induces cytochrome c release by a mitochondrial permeability transition-independent mechanism, J. Biol. Chem. 2002, 277, 31243-31248.
94. Halestrap, A. P., Calcíum, mitochondria and reperfusion injury: A pore way to die, Biochem. Soc. Trans. 2006, 34, 232-237.
95. Kurokawa, T., Kobayashi, H., Nonami, T., Harada, A. et al., Beneficial effects of cyclosporine on postischemic liver injury in rats, Transplantation 1992, 55, 308-311.
96. Bian, X., Hughes, F. M., Jr., Huang, Y., Cidlowski, J. A., Putney, J. W., Jr., Roles of cytoplasmic Ca2+ and intracellular Ca2+ stores in induction and suppression of apoptosis in S49 cells, Am. J. Physiol. 1997, 272, C1241-C1249.
97. Veenman, L., Papadopoulos, V., Gavish, M., Channel-like functions of the 18-kDa translocator protein (TSPO): Regulation of apoptosis and steroidogenesis as part of the host-defense response, Curr. Pharm. Des. 2007, 13, 2385-2405.
98. Mayer, R. J., Hubscher, G., Mitochondrial hexokinase from small-intestinal mucosa and brain, Biochem. J. 1971, 124, 491-500.
99. Azoulay-Zohar, H., Israelson, A., Abu-Hamad, S., Shoshan-Barmatz, V., In self-defence: Hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death, Biochem. J. 2004, 377, 347-355.
100. Nakashima, R. A., Hexokinase-binding properties of the mitochondrial VDAC protein: Inhibition by DCCD and location of putative DCCD-binding sites, J. Bioenerg. Biomembr. 1989, 21, 461-470.
101. Nakashima, R. A., Mangan, P. S., Colombini, M., Pedersen, P. L., Hexokinase receptor complex in hepatoma mitochondria: Evidence from N, N'-dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC, Biochemistry 1986, 25, 1015-1021.
102. Er, E., Oliver, L., Cartron, P. F., Juin, P. et al., Mitochondria as the target of the proapoptotic protein Bax, Biochim. Biophys. Acta 2006, 1757, 1301-1311.
103. Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C. et al., An inhibitor of Bcl-2 family proteins induces regression of solid tumours, Nature 2005, 435, 677-681.
104. Zhang, L., Ming, L., Yu, J., BH3 mimetics to improve cancer therapy; mechanisms and examples, Drug Resist. Updat. 2007, 10, 207-217.
105. Hetz, C., Vitte, P. A., Bombrun, A., Rostovtseva, T. K. et al., Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia, J. Biol. Chem. 2005, 280, 42960-42970.
106. Chelli, B., Falleni, A., Salvetti, F., Gremigni, V et al., Peripheral-type benzodiazepine receptor ligands: Mitochondrial permeability transition induction in rat cardiac tissue, Biochem. Pharmacol 2001, 61, 695-705.
107. Fennell, D. A., Corbo, M., Pallaska, A., Cotter, F. E., Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species, Br. J. Cancer. 2001, 84, 1397-1404.
108. Decaudin, D., Castedo, M., Nemati, F., Beurdeley-Thomas, A. et al., Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo, Cancer Res. 2002, 62, 1388-1393.
109. Decaudin, D., Peripheral benzodiazepine receptor and its clinical targeting, Anticancer Drugs 2004, 15, 737-745.
110. Walter, R. B., Pirga, J. L., Cronk, M. R., Mayer, S. et al., PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism, Blood 2005, 106, 3584-3593.
111. Walter, R. B., Raden, B. W., Cronk, M. R., Bernstein, I. D. et al., The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin, Blood 2004, 103, 4276-4284.
112. Gonzalez-Polo, R. A., Carvalho, G., Braun, T., Decaudin, D. et al., PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor, Oncogene 2005, 24, 7503-7513.
113. De Pinto, V., Messina, A., Accardi, R., Aiello, R. et al., New functions of an old protein: The eukaryotic porin or voltage dependent anion selective channel (VDAC), Ital. J. Biochem. 2003, 52, 17-24.
114. Lawen, A., Ly, J. D., Lane, D. J., Zarschiler, K. et al., Voltage-dependent anion-selective channel 1 (VDAC1) - a mitochondrial protein, rediscovered as a novel enzyme in the plasma membrane, Int. J. Biochem. Cell Biol. 2005, 37, 277-282.
115. Schein, S. J., Colombini, M., Finkelstein, A., Reconstitution in planar lipid bilayers of a voltage-dependent anion-selective channel obtained from paramecium mitochondria, J. Membr. Biol. 1976, 30, 99-120.
116. Colombini, M., A candidate for the permeability pathway of the outer mitochondrial membrane, Nature 1979, 279, 643-645.
117. Colombini, M., Regulation of the mitochondrial outer membrane channel, VDAC, J. Bioenerg. Biomembr. 1987, 19, 309-320.
118. Lemasters, J. J., Modulation of mitochondrial membrane permeability in pathogenesis, autophagy and control of metabolism, J. Gastroenterol. Hepatol. 2007, 22, S31-S37.
119. Shi, Y., Chen, J., Weng, C., Chen, R. et al., Identification of the protein-protein contact site and interaction mode of human VDAC1 with Bcl-2 family proteins, Biochem. Bio-phys. Res. Commun. 2003, 305, 989-996.
120. Shimizu, S., Konishi, A., Kodama, T., Tsujimoto, Y., BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death, Proc. Nail. Acad. Sci. USA 2000, 97, 3100-3105.
121. Vander Heiden, M. G., Li, X. X., Gottleib, E., Hill, R. B. et al., Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane, J. Biol. Chem. 2001, 276, 19414-19419.
122. Lemasters, J. J., Holmuhamedov, E., Voltage-dependent anion channel (VDAC) as mitochondrial governator-thinking outside the box, Biochim. Biophys. Acta 2006, 1762, 181-190.
123. Thinnes, F. P., Florke, H., Winkelbach, H., Stadtmuller, U. et al., Channel active mammalian porin, purified from crude membrane fractions of human B lymphocytes or bovine skeletal muscle, reversibly binds the stilbene-disulfonate group of the chloride channel blocker DIDS, Biol. Chem. Hoppe Seyler 1994, 375, 315-322.
124. Tomaskova, Z., Gaburjakova, J., Brezova, A., Gaburjakova, M., Inhibition of anion channels derived from mitochondrial membranes of the rat heart by stilbene disulfonate-DIDS, J. Bioenerg. Biomembr. 2007, 39, 301-311,
125. Siadat, S., Reymann, S., Horn, A., Thinnes, F. P., Studies on human porin XVIII: The multicompartment effector ruthenium red reduces the voltage dependence of human VDAC in planar lipid bilayers, Mol. Genet. Metab. 1998, 65, 246-249.
126. Gincel, D., Zaid, H., Shoshan-Barmatz, V., Calcium binding and translocation by the voltage-dependent anion channel: A possible regulatory mechanism in mitochondrial function, Biochem. J. 2001, 358, 147-155.
127. Bahamonde, M. I., Fernandez-Fernandez, J. M., Guix, F. X., Vazquez, E., Valverde, M. A., Plasma membrane voltage-dependent anion channel mediates antiestrogen-activated maxi Cl-currents in C1300 neuroblastoma cells, J. Biol. Chem. 2003, 278, 33284-33289.
128. Baker, M. A., Lane, D. J., Ly, J. D., De Pinto, V., Lawen, A., VDACI is a transplasma membrane NADH-ferricyanide reductase, J. Biol. Chem. 2004, 279, 4811-4819.
129. Bathori, G., Parolini, I., Tombola, F., Szabo, I. et al., Porin is present in the plasma membrane where it is concentrated in caveolae and caveolae-related domains, J. Biol. Chem. 1999, 274, 29607-29612.
130. Buettner, R., Papoutsoglou, G., Scemes, E., Spray, D. C., Dermietzel, R., Evidence for secretory pathway localization of a voltage-dependent anion channel isoform, Proc. Natl. Acad. Sci. USA 2000, 97, 3201-3206.
131. Dermietzel, R., Hwang, T. K., Buettner, R., Hofer, A. et al., Cloning and in situ localization of a brain-derived porin that constitutes a large-conductance anion channel in astrocytic plasma membranes, Proc. Natl. Acad. Sci. USA 1994, 91, 499-503.
132. Gonzalez-Gronow, M., Kalfa, T., Johnson, C. E., Gawdi, G., Pizzo, S. V., The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells, J. Biol. Chem. 2003, 273, 27312-27318.
133. Okada, S. F., O'Neal, W. K., Huang, P., Nicholas, R. A. et al., Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in murine cells, J. Gen. Physiol. 2004, 124, 513-526.
134. Thinnes, F. P., Evidence for extra-mitochondrial localization of the VDAC/porin channel in eucaryotic cells, J. Bioenerg. Biomembr. 1992, 24, 71-75.
135. Blatz, A. L., Magleby, K. L., Single voltage-dependent chloride-selective channels of large conductance in cultured rat muscle, Biophys. J. 1983, 43, 237-241.
136. Jalonen, T., Johansson, S., Holopainen, I., Oja, S. S., Arhem, P., A high-conductance multi-state anion channel in cultured rat astrocytes, Acta Physiol. Scand. 1989, 136, 611-612.
137. Deleonardi, G., Biondi, A., D'Aurelio, M., Pich, M. M. et al. Plasma membrane oxidoreductase activity in cultured cells in relation to mitochondrial function and oxidative stress, Biofactors 2004, 20, 251-258.
138. Herst, P. M., Petersen, T., Jerram, P., Baty, J., Berridge, M. V., The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells, Biochem, Pharmacol. 2007, 74, 1587-1595.
139. Herst, P. M., Tan, A. S., Scarlett, D. J., Berridge, M. V., Cell surface oxygen consumption by mitochondrial gene knockout cells, Biochim. Biophys. Acta 2004, 1656, 79-87.
140. Hyun, D. H., Hunt, N. D., Emerson, S. S., Hernandez, J. O. et al., Up-regulation of plasma membrane-associated redox activities in neuronal cells lacking functional mitochondria, J. Neurochem. 2007, 100, 1364-1374.
141. Larm, J. A., Vaillant, F., Linnane, A. W., Lawen, A., Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells, J. Biol. Chem. 1994, 269, 30097-30100.
142. Malik, S. G., Vaillant, F., Lawen, A., Plasma membrane NADH-oxidoreductase in cells carrying mitochondrial DNA G11778A mutation and in cells devoid of mitochondrial DNA (rho0), Biofactors 2004, 20, 189-198.